Lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH) is only becoming more prevalent as the population ages. There are many treatment options available from pharmacologic therapy, to endoscopic procedures to open or robotic surgery. The historical standard for endoscopic management of LUTS due to BPH has long been the transurethral resection of prostate (TURP). Although pharmacologic therapy can be effective, it is met with many dissatisfying and troublesome side effects for men. There has been a need for something to bridge the gap between pharmacotherapy and endoscopic management, such as a TURP.